Learn More
Medchemexpress LLC 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(3-phenoxybenzyl)piperazine-1-carboxylate | 1416133-89-5 | MFCD22987956 | 99.9% | 462.39 | C21H20F6N2O3 | 50MG

Supplier: Medchemexpress LLC HY1233250MG
JW-642 is a research-grade, selective inhibitor of monoacylglycerol lipase (MAGL) used to probe endocannabinoid signaling and lipid metabolism. It provides low-nanomolar potency against MAGL across species while showing much weaker activity against fatty acid amide hydrolase, supporting its use as a selective pharmacological tool.
- Potent MAGL inhibition in human, mouse, and rat (IC50: 3.7 nM human; 7.6 nM mouse; 14 nM rat).
- Reduced activity versus FAAH (micromolar IC50s), indicating selectivity.
- High purity (99.9% by HPLC) for consistent experimental performance.
- Solid, stable material suitable for analytical and preparative applications.
- Recommended storage under nitrogen at 4°C; in solution store at -80°C for long-term stability.
- Suitable for biochemical, enzymatic, and cell-based assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.